MRKR Average Annual Return 10 Years

Growth of $10,000.00
Without Dividends Reinvested Into MRKR

Also see:
• MRKR stock yearly return 2014
• MRKR stock yearly return 2015
• MRKR stock yearly return 2016
• MRKR stock yearly return 2017
• MRKR stock yearly return 2018
• MRKR stock yearly return 2019
• MRKR stock yearly return 2020
• MRKR stock yearly return 2021
• MRKR stock yearly return 2022
• MRKR stock yearly return 2023
• MRKR YTD return

Compare MRKR average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return

Start date:	10/14/2014
End date:	10/11/2024
Start price/share:	$5.00
End price/share:	$2.71
Dividends collected/share:	$0.00
Total return:	-45.80%
MRKR Average Annual Return:	-5.94%
Starting investment:	$10,000.00
Ending investment:	$5,420.63
Years:	10.00

MRKR average annual return is presented with the assumption of reinvestments of any dividends on ex-date.

Marker Therapeutics is a clinical-stage immuno-oncology company engaging in the development and commercialization of T cell-based immunotherapies and peptide-based vaccines. Co. is developing three product candidates, including: autologous treatment of lymphoma, and selected solid tumors; allogeneic T cells for the treatment of acute myeloid leukemia (AML); and off-the-shelf products in various indications. Co.'s clinical development programs are: MT-401, which is for the treatment of post-transplant AML; MT-401-OTS, which is for the treatment of AML; MT-601, which is for the treatment of pancreatic cancer; and MT-601, which is for the treatment of lymphoma. The MRKR average annual return 10 years is shown above.

The Average Annual Return on the MRKR average annual return 10 years page and across the coverage universe of our site, is a measure of the annualized return over the past ten years (or specified start date) for a given investment (up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window to capture long-term trends.

Thus, researching Average Annual Returns is good practice for investors — whether MRKR average annual return 10 years or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the MRKR average annual return calculation with any dividends reinvested as applicable (on ex-dates).

Quotes delayed 20 minutes

Free MRKR Email Alerts:
Get Dividend Alerts

Get SEC Filing Alerts

10 Most Oversold Stocks in the S&P

10 Most Overbought Stocks in the S&P

10 ETFs With Stocks That Insiders Are Buying

10 ETFs With Most Upside To Analyst Targets

The DividendRank Top 25

Warren Buffett Dividend Stocks

10 Cheap Dividend Stocks Under $10

10 Energy Stocks You Can Buy Cheaper Than Insiders Did

10 Top DividendRank'ed Energy Stocks

The 10 Highest Yielding Preferred Stocks

The 15 Most Active Call & Put Options of the S&P 500 Components

Video: Don't Forget Dividends in Average Annual Return!

If the video does not load after a few moments, Upgrade to the Latest Flash Player.

Marker Therapeutics (MRKR) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

MRNA Average Annual Return
MRNS Average Annual Return
MRSN Average Annual Return
MRVI Average Annual Return
MTEM Average Annual Return
MXCT Average Annual Return
MYGN Average Annual Return
MYND Average Annual Return
NAOV Average Annual Return
NARI Average Annual Return
More Healthcare companies »

What has the average annual return been for MRKR over the past ten years?

✔️Accepted answer: The ten year MRKR average annual return has been -5.94%.

What start date was used in your MRKR average annual return calculation?

✔️Accepted answer: The start date was 10/14/2014.

What end date was used in your MRKR average annual return calculation?

✔️Accepted answer: The end date was 10/11/2024.

If I had invested $10,000 into MRKR ten years ago, how much would I have today?

✔️Accepted answer: Today, as of 10/11/2024, you would have $5,420.63.

What does that work out to on a total return basis?

✔️Accepted answer: The MRKR ten year total return ending 10/11/2024 works out to -45.80%.

MRKR Average Annual Return 10 Years | www.AverageAnnualReturn.com | Copyright © 2021 - 2024, All Rights Reserved